Work

Uncertain Prognosis for High-Quality Diagnostics: Clinical Challenges, Economic Barriers and Needed Reforms

Year: 2013

Type: article

Source: Pharmacogenomics

DOI: 10.2217/pgs.13.3

Authors: Mark R Trusheim, MJ Finley Austin, Carsten Rausch, Ernst R Berndt

Institutions: Massachusetts Institute of Technology, AstraZeneca (United States), F. Hoffmann-La Roche AG

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2058380554

FWCI: 8.582

Cites: 28

Cited by: 15

Related to: 10